Skip to content

Clinical Randomized Controlled Trial for the Treatment of Hashimoto's Thyroiditis by Hand Yangming Transthoracic Acupuncture

Clinical Randomized Controlled Trial for the Treatment of Hashimoto's Thyroiditis by Hand Yangming Transthoracic Acupuncture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002701
Enrollment
Unknown
Registered
2019-10-23
Start date
2019-10-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto's thyroiditis

Interventions

Sponsors

Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for Hashimoto's thyroiditis; (2) Aged 18-70 years; (3) In the past 1 month, the serum thyroid hormone was found to be at a normal level, and the exogenous levothyroxine was regularly administered; (4) Willing to cooperate with acupuncture treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Thyroid stimulating hormone receptor antibody (TRAb) positive, and suspected of combining Graves disease or Hashimoto's hyperthyroidism; (2) Highly suspected thyroid malignancy; (3) Highly suspected subacute thyroiditis; (4) Have undergone thyroid surgery; (5) Accepting western medicine treatment (such as selenium supplementation treatment) other than the treatment of exogenous thyroid hormone, or taking Chinese medicine containing iodine in the past month; (6) Have a combination of severe cardiovascular, cerebrovascular, liver, kidney, and blood system diseases; (7) Suffering from mental or mental illness; (8) Pregnancy or lactation women; (9) Have contraindications to experimental therapy, including infection or severe skin lesions on the skin at the needle site, fainting of the subject, severe fear of needles, etc..

Design outcomes

Primary

MeasureTime frame
thyroid hormone;Thyroid autoantibody;

Secondary

MeasureTime frame
ThyPRO;SF-36;HAD scale;

Countries

China

Contacts

Public ContactShanze Wang

Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine

wangshanze2012@163.com+86 18811300928

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026